EyePoint Pharmaceuticals News

EyePoint Pharmaceuticals | 8-K: Current report

Sep 4 19:10

EyePoint Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 9 04:50

EyePoint Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Aug 9 04:47

EyePoint Pharmaceuticals | 8-K: EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Developments

Aug 7 19:01

EyePoint Pharmaceuticals | 8-K: Current report

Jun 26 21:28

EyePoint Pharmaceuticals | 8-K: Current report

Jun 21 19:06

EyePoint Pharmaceuticals | 8-K: Current report

May 28 19:11

EyePoint Pharmaceuticals | 8-K: EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments

May 8 19:08

EyePoint Pharmaceuticals | 8-K: Current report

May 6 21:28

EyePoint Pharmaceuticals | DEFA14A: Others

Apr 27 04:06

EyePoint Pharmaceuticals | DEF 14A: Definitive information statements

Apr 27 04:06

EyePoint Pharmaceuticals | 8-K: EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments

Mar 7 20:09

EyePoint Pharmaceuticals | 8-K: Current report

Mar 4 20:05

EyePoint Pharmaceuticals | 8-K: Current report

Jan 10 13:00

EyePoint Pharmaceuticals | 8-K: Current report

Dec 9, 2023 05:02

EyePoint Pharmaceuticals | 8-K: Current report

Dec 8, 2023 07:11

EyePoint Pharmaceuticals | 8-K: Current report

Dec 4, 2023 20:05

EyePoint Pharmaceuticals | 8-K: Current report

Nov 9, 2023 21:00

EyePoint Pharmaceuticals | 8-K: EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments

Nov 1, 2023 19:05

EyePoint Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Oct 21, 2023 05:18